ProtokolPROTOKOL
Medication

Dasatinib (prescription)

Half-life

~3–5 hours

What is Dasatinib (prescription)?

Prescription tyrosine-kinase inhibitor used off-label in senolytic 'D+Q' protocols (dasatinib + quercetin) to clear senescent cells. Pulsed dosing only, under medical supervision.

How Dasatinib (prescription) works

Inhibits pro-survival tyrosine kinases (SRC/ephrin) that senescent cells depend on, triggering their apoptosis; paired with quercetin for broader senolytic coverage.

Benefits & uses

Common uses: Senolytic (with quercetin), senescent-cell clearance research protocols.

Dasatinib (prescription) dosage

Protokol doesn't recommend doses for prescription or controlled compounds. Any figures below are reference or observational reports — dosing should be set with a qualified clinician.

Typical dose
Research/clinic D+Q protocol: intermittent 2-3 day pulses, physician-supervised only.

Dasatinib (prescription) half-life

~3–5 hours (plasma)

Dasatinib (prescription) side effects

  • Prescription-only — significant drug with cytopenia/effusion risks
  • Not for unsupervised use
  • Numerous drug interactions (CYP3A4)

Commonly stacked with

QuercetinFisetin

Track Dasatinib (prescription) in Protokol.

Log doses, model half-lives, check interactions, and line it all up against your bloodwork. Free on iPhone and Android.

Download on the App StoreGet it on Google Play

For research and educational purposes only. This page is not medical advice and is not a recommendation to use any compound. Many compounds listed are not approved for human use, and some are prescription-only or controlled in your jurisdiction. Dosing figures are reference or observational reports. Talk to a qualified healthcare provider before starting, stopping, or changing anything. Protokol is for tracking purposes only.